Islet ß cell function in latent autoimmune diabetes in adults with islet cell antibodies

Journal of Central South University (Medical Sciences)

Volumn 29, Issue 3, 2004, Pages 309-314

  Yang, Li ^a   Zhou, Zhi Guang ^a   Huang, Gan ^a   Yan, Xiang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Glutamic acid decarboxylase antibody; Islet cell function; Islet cell antibody; Latent autoimmune diabetes in adults

Indexed keywords

ANTIBODY; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; BLOOD; DIABETES MELLITUS; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PANCREAS ISLET; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; ANTIBODIES; AUTOANTIBODIES; AUTOIMMUNE DISEASES; DIABETES MELLITUS; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; ISLETS OF LANGERHANS; MALE; MIDDLE AGED;

EID: 33846458326     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Tuomi T, Groop LC, Zhnmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease [J]. Diabetes, 1993, 42 (2) : 359-362. (Pubitemid 23045043)
2. Theophanides CG, Pyke DA, Watkins PJ. Islet function in diabetics with persistent islet cell antibodies [J]. Diabetes, 1978, 27 (suppl 1) : 265-266. (Pubitemid 8303584)
3. Torn C, Landin-Olsson M, Lernmark A, et al. Combinations of beta cell specific autoantibodies at diagnosis of diabetes in young adults re fleet different courses of beta cell damage [J]. Autoimmunity, 2001, 33 (2) :115-120.
4. Nakanishi K, Kobayashi T, Myashita H, et al. Relationships among islet cell antibodies, residual ß-cell function, and metabolic control in patients with insulin-dependent diabetes of long duration : use of a sensitive C-peptide radioimmunoassay [J]. Metabolism, 1999, 39 (9) : 925-930.
5. Wagner R, Cenorese S, Bosi E, et al. Slow metabolic deterioration towards diabetes in ICA positive patients with autoimmune polyendocrine disease [J]. Diabetologia, 1994, 37 (4) : 365-371. (Pubitemid 24113567)
6. Kohnert KD, Besch W, Rjasanowski I. Discordant results in the assay of cytoplasmic islet cell autoantibodies with ELISA and immunohistochemical techniques [J ]. Eur J Clin Chem Clin Biochem, 1995, 33 (7) : 447-449.
7. Bonifacio E, Genovese S, Braghi S, et al. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity [J]. Diabetologia, 1995, 38 (7) : 816-822.
8. Schmidli RS, Colman PC, Bonifacio E. participating laboratories : Disease sensitivity and specificity of fifty-two assays for glutamic acid decarboxylase antibodies : the Second International GAD-Ab Workshop [J]. Diabetes, 1995, 44 (6) : 636-640.
9. Gbttsater A, Lernmark A, Landin-Olsson M, et al. ß-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients [J]. Diabetes Care, 1993, 16 (6) : 902-909.
10. Turner R, Stratton I, Horton V, et al. UKPDS25 : autoantibodies to ICA and GAD for prediction of insulin requirement in type 2 diabetes [J]. Lancet, 1997, 350 (9087) : 1288-1293. (Pubitemid 28036638)
11. Borg H, Gbttsater A, Landin-Olsson M, et al. High levels of antigen specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age [J]. J Clin Endocrinol Metab, 2001, 86 (7) : 3032-3038.
12. Torn C, Landin-Olsson M, Lernmark A, et al. Prognostic factors for the course of beta cell function in autoimmune diabetes [J]. J Clin Endocrinol Mstab, 2000, 85 (12) :4619-4623.
13. Lohmann T, Kellner K, Verlohren H, et al. Titer and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA) [J]. Diabetologia, 2001, 44 (8) : 1005-1010. (Pubitemid 32778132)
14. Borg H, Gbttsater A, Fernlund P, et al. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adulťonset diabetes [J ]. Diabetes, 2002, 51 (6) :1754-1762.
15. Seissler J, Sonnaville JJ, Abrgenthaler NG, et al. Immunological heterogeneity in Type 1 diabetes : presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease [J]. Diabetologia, 1998, 41 (8) : 891-897.
16. Antonelli A, Tuomi T, Nannipieri M, et al. Autoimmunity to CD38 and GAD in type I and type II diabetes : CD38 and HLA genotypes and clinical phenotypes [J]. Diabetologia, 2002, 45 (9) : 1298-1306.